Biodegradable silica nanoparticles for efficient linear DNA gene delivery

References

• Bharali DJ, Klejbor I, Stachowiak EK, et al. (2005). Organically modified silica nanoparticles: A nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci U S A 102:11539–44. doi: 10.1073/pnas.0504926102.
   PubMed Web of Science ®Google Scholar
• Bock C-T, Franz S, Zentgraf H, Sommerville J. (2006). Electron microscopy of biomolecules. In Encyclopedia of molecular cell biology and molecular medicine, 103–128. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA.
   Google Scholar
• Buck J, Grossen P, Cullis PR, et al. (2019). Lipid-based DNA therapeutics: Hallmarks of non-viral gene delivery. ACS Nano 13:3754–82. doi: 10.1021/acsnano.8b07858.
   PubMed Web of Science ®Google Scholar
• Chen J, Guo Z, Tian H, Chen X. (2016). Production and clinical development of nanoparticles for gene delivery. Mol Ther Methods Clin Dev 3:16023. doi: 10.1038/mtm.2016.23.
   PubMed Web of Science ®Google Scholar
• Cox S, Sandall A, Smith L, et al. (2021). Food additive emulsifiers: a ­review of their role in foods, legislation and classifications, presence in food supply, dietary exposure, and safety assessment. Nutr Rev 79:726–41. doi: 10.1093/nutrit/nuaa038.
   PubMed Web of Science ®Google Scholar
• Cring MR, Sheffield VC. (2020). Gene therapy and gene correction: targets, progress, and challenges for treating human diseases. Gene Ther 29:3–12. doi: 10.1038/s41434-020-00197-8.
   PubMed Web of Science ®Google Scholar
• Croissant JG, Butler KS, Zink JI, Brinker CJ. (2020). Synthetic amorphous silica nanoparticles: toxicity, biomedical and environmental implications. Nat Rev Mater 5:886–909. doi: 10.1038/s41578-020-0230-0.
   Web of Science ®Google Scholar
• Das PR, Sherif SM. (2020). Application of exogenous dsRNAs-induced RNAi in agriculture: challenges and triumphs. Front Plant Sci 11:946. doi: 10.3389/fpls.2020.00946.
   PubMed Web of Science ®Google Scholar
• Doudna JA. (2020). The promise and challenge of therapeutic genome editing. Nature 578:229–236. doi: 10.1038/s41586-020-1978-5.
   PubMed Web of Science ®Google Scholar
• Duan L, Yan Y, Liu J, et al. (2016). Target delivery of small interfering RNAs with vitamin E-coupled nanoparticles for treating hepatitis C. Sci Rep 6:24867. doi: 10.1038/srep24867.
   PubMed Web of Science ®Google Scholar
• Everton E, Rizvi F, Smith AR, et al. (2021). Transient yet robust expression of proteins in the mouse liver via intravenous injection of lipid nanoparticle-encapsulated nucleoside-modified mRNA. Bio Protoc 11:e4184. doi: 10.21769/BioProtoc.4184.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Brown AM, Jenkins C, Campbell K. (2020). Viral vector systems for gene therapy: a comprehensive literature review of progress and biosafety challenges. Appl Biosaf 25:7–18. doi: 10.1177/1535676019899502.
   PubMedGoogle Scholar
• González-Domínguez E, Iturrioz-Rodríguez N, Padín-González E, et al. (2017). Carbon nanotubes gathered onto silica particles lose their biomimetic properties with the cytoskeleton becoming biocompatible. Int J Nanomedicine 12:6317–28. doi: 10.2147/IJN.S141794.
   PubMed Web of Science ®Google Scholar
• Guimarães D, Cavaco-Paulo A, Nogueira E. (2021). Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm 601:120571. doi: 10.1016/j.ijpharm.2021.120571.
   PubMed Web of Science ®Google Scholar
• High KA, Roncarolo MG. (1996). Gene therapy. Scientist 10:455–64.
   Google Scholar
• Huang X, Li L, Liu T, et al. (2011). The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano 5:5390–9. doi: 10.1021/nn200365a.
   PubMed Web of Science ®Google Scholar
• Iturrioz-Rodríguez N, Correa-Duarte M, Fanarraga ML. (2019). Mesoporous silica particles as controlled drug delivery systems in cancer. Int J Nanomedicine 14:3389–401. doi: 10.2147/IJN.S198848.
   PubMed Web of Science ®Google Scholar
• Iturrioz-Rodríguez N, Correa-Duarte MA, Valiente R, Fanarraga ML. (2020). Engineering sub-cellular targeting strategies to enhance safe cytosolic silica particle dissolution in cells. Pharmaceutics 12:487. doi: 10.3390/pharmaceutics12060487.
   PubMed Web of Science ®Google Scholar
• Jackson HJ, Rafiq S, Brentjens RJ. (2016). Driving CAR T-cells forward. Nat Rev Clin Oncol 13:370–83. doi: 10.1038/nrclinonc.2016.36.
   PubMed Web of Science ®Google Scholar
• Janjua TI, Cao Y, Yu C, Popat A. (2021). Clinical translation of silica nanoparticles. Nat Rev Mater 6:1072–4. doi: 10.1038/s41578-021-00385-x.
   PubMed Web of Science ®Google Scholar
• Kapusuz D, Durucan C. (2017). Exploring encapsulation mechanism of DNA and mononucleotides in sol-gel derived silica. J Biomater Appl 32:114–25. doi: 10.1177/0885328217713104.
   PubMed Web of Science ®Google Scholar
• Koudelka KJ, Pitek AS, Manchester M, Steinmetz NF. (2015). Virus-based nanoparticles as versatile nanomachines. Annu Rev Virol 2:379–401. doi: 10.1146/annurev-virology-100114-055141.
   PubMed Web of Science ®Google Scholar
• Lehman SE, Mudunkotuwa IA, Grassian VH, Larsen SC. (2016). Nano-bio interactions of porous and nonporous silica nanoparticles of varied surface chemistry: a structural, kinetic, and thermodynamic study of protein adsorption from rpmi culture medium. Langmuir 32:731–42. doi: 10.1021/acs.langmuir.5b03997.
   PubMed Web of Science ®Google Scholar
• Lehner R, Wang X, Hunziker P. (2013). Plasmid linearization changes shape and efficiency of transfection complexes. Eur J Nanomed. 5:205–12.
   Google Scholar
• Li Z, Barnes JC, Bosoy A, et al. (2012). Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev 41:2590–605. doi: 10.1039/c1cs15246g.
   PubMed Web of Science ®Google Scholar
• Lu J, Liong M, Li Z, et al. (2010). Efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6:1794–805. doi: 10.1002/smll.201000538.
   PubMed Web of Science ®Google Scholar
• Luo WC, Lu X. (2023). Solid lipid nanoparticles for drug delivery. Methods Mol Biol 2622:139–46. doi: 10.1007/978-1-0716-2954-3_12.
   PubMedGoogle Scholar
• Lv Z, Jiang R, Chen J, Chen W. (2020). Nanoparticle-mediated gene transformation strategies for plant genetic engineering. Plant J 104:880–91. doi: 10.1111/tpj.14973.
   PubMed Web of Science ®Google Scholar
• Mitchell MJ, Billingsley MM, Haley RM, et al. (2021). Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 20:101–24. doi: 10.1038/s41573-020-0090-8.
   PubMed Web of Science ®Google Scholar
• Navarro-Palomares E, González-Saiz P, Renero-Lecuna C, et al. (2020). Dye-doped biodegradable nanoparticle SiO2 coating in zinc- and iron-oxide nanoparticles to improve biocompatibility and in vivo imaging studies. Nanoscale 12:6164–75. doi: 10.1039/c9nr08743e.
   PubMed Web of Science ®Google Scholar
• Paris JL, Vallet-Regí M. (2020). Mesoporous silica nanoparticles for co-delivery of drugs and nucleic acids in oncology: A review. Pharmaceutics 12:526. doi: 10.3390/pharmaceutics12060526.
   PubMed Web of Science ®Google Scholar
• Puri A, Loomis K, Smith B, et al. (2009). Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst 26:523–80. doi: 10.1615/critrevtherdrugcarriersyst.v26.i6.10.
   PubMed Web of Science ®Google Scholar
• Ramos-Valle A, Marín-Caba L, Hevia LG, et al. (2023). One-pot synthesis of compact DNA silica particles for gene delivery and extraordinary DNA preservation. Mater. Today Adv 18:100357. doi: 10.1016/j.mtadv.2023.100357.
   Google Scholar
• Rodríguez-Ramos A, Marín-Caba L, Iturrioz-Rodríguez N, et al. (2020). Design of polymeric and biocompatible delivery systems by dissolving mesoporous silica templates. Int J Mol Sci 21:1–15.
   Web of Science ®Google Scholar
• Shahryari A, Burtscher I, Nazari Z, Lickert H. (2021). Engineering gene therapy: advances and barriers. Adv Ther 4:2100040.
   Google Scholar
• Torney F, Trewyn BG, Lin VSY, Wang K. (2007). Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat Nanotechnol 2:295–300. 2007 25 doi: 10.1038/nnano.2007.108.
   PubMed Web of Science ®Google Scholar
• Wei T, Cheng Q, Min YL, et al. (2020). Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing. Nat Commun 11:3232. doi: 10.1038/s41467-020-17029-3.
   PubMed Web of Science ®Google Scholar
• Winchester B. (1982). Animal models of human genetic diseases. Trends Biochem. Sci 7:71–4. doi: 10.1016/0968-0004(82)90081-0.
   Web of Science ®Google Scholar
• Yeh CD, Richardson CD, Corn JE. (2019). Advances in genome editing through control of DNA repair pathways. Nat Cell Biol 21:1468–78. doi: 10.1038/s41556-019-0425-z.
   PubMed Web of Science ®Google Scholar